Summary: Experimentica receives 1.09 m€ in EU funding for the development of a human cornea transplantation model along with long-time partner Ferentis UAB.
Experimentica Ltd. Lithuania, announces that they received a 1.09 m€ “Intellect. Business and research cooperation projects” competitive award from the Lithuanian Business Support Agency. The funding is a part of the European Union programme “Promotion of Scientific Research, Experimental Development and Innovations Priority of the Operational Programme of the European Union Structural Funds for 2014-2020”.
The objectives of the research include the development of innovative method for corneal transplantation, the development of biosynthetic cornea for regenerative medicine, and the use of artificial model mimicking human cornea used for drug permeability tests.
“We are honored to receive EU funding and thankful to Lithuanian Business Support Agency for their trust in our R&D excellence. Recent advances in biomaterial sciences (BioCornea) give us hope that newly synthetized biologically active collagen peptide sequences can be successfully applied in the field of human cornea transplantation. The project will be implemented along with the team of Ferentis UAB, our long-lasting collaborators from research projects previously funded by Eurostars program”, said Dr. Simon Kaja, Chief Scientific Officer and VP, Americas of Experimentica.